| 专利名称 | COMBINATION OF HUMAN ANTI-FGFR4 ANTIBODY AND SORAFENIB | ||
| 申请号 | US16076776 | 申请日 | |
| 公开（公告）号 | US20190048088A1 | 公开（公告）日 | 2017-02-09 |
| 申请（专利权）人 | 发明人 | Reimar Abraham; Keisuke Fukuchi | |
| 专利来源 | 国家知识产权局 | 转化方式 | |
| 摘要 |
The present invention relates to the medical use of antibodies against the FGF receptor 4 (FGFR4) combined with Sorafenib, in particular for the prevention or treatment of hyperproliferative diseases associated with FGFR expression, overexpression or hyperactivity. |
||
主管部门：海南中小企业服务 | 建设单位：海南商业联合会
版权所有：海南商业联合会 | 备案号：粤ICP备13083911号（ICP加挂服务）@2017
